A Novel SCN9A Mutation Responsible for Primary Erythromelalgia and Is Resistant to the Treatment of Sodium Channel Blockers

Por Wu, Min-Tzu, Huang, Po-Yuan, Yen, Chen-Tung, Chen, Chih-Cheng, Lee, Ming-Jen
Publicado em 2013

The Biophysical Basis Underlying Gating Changes in the p.V1316A Mutant Na(v)1.7 Channel and the Molecular Pathogenesis of Inherited Erythromelalgia

Por Huang, Chiung-Wei, Lai, Hsing-Jung, Huang, Po-Yuan, Lee, Ming-Jen, Kuo, Chung-Chin
Publicado no PLoS Biol (2016)

Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden

Por Johansson, Gunnar, Peng, Po-Chun, Huang, Po-Yuan, Chien, Hsiung-Fei, Hua, Kuo-Tai, Kuo, Min-Liang, Chen, Chin-Tin, Lee, Ming-Jen
Publicado no PLoS One (2014)